Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013:2013:787981.
doi: 10.1155/2013/787981. Epub 2013 Jan 15.

Mulberry leaf reduces oxidation and C-reactive protein level in patients with mild dyslipidemia

Affiliations
Clinical Trial

Mulberry leaf reduces oxidation and C-reactive protein level in patients with mild dyslipidemia

Pornanong Aramwit et al. Biomed Res Int. 2013.

Abstract

C-reactive protein (CRP) is the inflammatory marker that could represent the inflammation in blood vessels resulted from dyslipidemia. The objective of this study was to evaluate the antioxidative activity of mulberry leaf powder using DPPH assay and the effect of mulberry leaf powder on lipid profile, CRP level, and antioxidative parameters in mild dyslipidemia patients. A within-subjects design was conducted and patients received three tablets of 280 mg mulberry leaf powder three times a day before meals for 12 weeks. Total of 25 patients were enrolled but one subject was excluded. After three months of mulberry leaf consumption, serum triglyceride and low-density lipoprotein (LDL) level were significantly reduced and more than half of all patients' CRP levels decreased every month as well as the mean CRP level but no statistically significant difference was found. The average erythrocyte glutathione peroxidase activity of patients was increased but not at significant level; however, the mean serum 8-isoprostane level was significantly lower after mulberry treatment for 12 weeks. It can be concluded that mulberry leaf powder exhibited antioxidant activity and mulberry leaf powder has potential to decrease serum triglyceride, LDL, and CRP levels in mild dyslipidemia patients without causing severe adverse reactions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IC50 of mulberry leaf extracts at room temperature.
Figure 2
Figure 2
Mean CRP level of subjects in each month (n = 24).

References

    1. Kang TH, Hur JY, Kim HB, Ryu JH, Kim SY. Neuroprotective effects of the cyanidin-3-O-beta-d-glucopyranoside isolated from mulberry fruit against cerebral ischemia. Neuroscience Letters. 2006;391(3):122–126. - PubMed
    1. Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions. Life Sciences. 2005;77(26):3344–3354. - PubMed
    1. Aramwit P, Petcharat K, Supasyndh O. Efficacy of mulberry leaf tablets in patients with mild dyslipidemia. Phytotherapy Research. 2011;25(3):365–369. - PubMed
    1. Enkhmaa B, Shiwaku K, Katsube T, et al. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. Journal of Nutrition. 2005;135(4):729–734. - PubMed
    1. Harauma A, Murayama T, Ikeyama K, et al. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice. Biochemical and Biophysical Research Communications. 2007;358(3):751–756. - PubMed

Publication types